Multiplex single molecule counting technology used to generate interleukin 4, interleukin 6, and interleukin 10...

Area of Science:

• Biotechnology and Biomedical Engineering
• Clinical Diagnostics and Biomarker Discovery

Background:

• Accurate detection of biomarkers at picogram per milliliter (pg/ml) concentrations is crucial for understanding health and disease states.
• Multiplex detection of multiple biomarkers from single samples enhances diagnostic accuracy, testing efficiency, and reduces sample volume requirements.

Purpose of the Study:

• To design and construct a multiplex instrument based on single molecule counting technology.
• To assess the instrument's capability in detecting low-abundance proteins and cytokines in human plasma at sub-pg/ml levels.
• To establish 95% reference limits for key cytokines in healthy individuals.

Main Methods:

• Development of a novel multiplex instrument utilizing single molecule counting technology.
• Analysis of 100 healthy human donor plasma samples.
• Quantification of interleukin 4 (IL-4), interleukin 6 (IL-6), and interleukin 10 (IL-10) concentrations.

Main Results:

• The multiplex single molecule counting instrument successfully detected cytokines at sub-pg/ml quantities.
• Established 95% reference limits: IL-4 (<0.61 pg/ml), IL-6 (<6.53 pg/ml), and IL-10 (<1.08 pg/ml).
• Achieved high detection rates: >90% for IL-4 and 100% for IL-6 and IL-10 above the limit of detection.

Conclusions:

• The developed multiplex instrument enables sensitive detection of low-abundance protein biomarkers in human plasma.
• This technology facilitates accurate quantification of cytokines, crucial for early disease detection and monitoring.
• The established reference limits provide a benchmark for clinical interpretation of IL-4, IL-6, and IL-10 levels.